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Laboratory experiments show that social interactions between
bacterial cells can drive evolutionary change at the population level,
but significant challenges limit attempts to assess the relevance of
these findings to natural populations, where selection pressures are
unknown. We have increasingly sophisticated methods for moni-
toring phenotypic and genotypic dynamics in bacteria causing
infectious disease, but in contrast, we lack evidence-based adaptive
explanations for those changes. Evolutionary change during in-
fection is often interpreted as host adaptation, but this assumption
neglects to consider social dynamics shown to drive evolutionary
change in vitro. We provide evidence to show that long-term
behavioral dynamics observed in a pathogen are driven by selection
to outcompete neighboring conspecific cells through social inter-
actions. We find that Pseudomonas aeruginosa bacteria, causing
lung infections in patients with cystic fibrosis, lose cooperative iron
acquisition by siderophore production during infection. This loss
could be caused by changes in iron availability in the lung, but
surprisingly, we find that cells retain the ability to take up sidero-
phores produced by conspecifics, even after they have lost the abil-
ity to synthesize siderophores. Only when cooperative producers are
lost from the population is the receptor for uptake lost. This finding
highlights the potential pitfalls of interpreting loss of function in
pathogenic bacterial populations as evidence for trait redundancy
in the host environment. More generally, we provide an example of
how sequence analysis can be used to generate testable hypotheses
about selection driving long-term phenotypic changes of pathogenic
bacteria in situ.
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Some of the most important bacterial pathogens are oppor-tunistic in the sense that they infect a compromised human
host from the surrounding environment. In cases where such
infections become persistent, the evolutionary changes accom-
panying the transition from the environment to the human body
have been the subject of intensive research, and we now have
some information on what distinguishes clinical from environ-
mental isolates (1). Surprisingly, our understanding of how this
process is driven by selection often remains speculative. To study
bacterial cells, we must remove them from the host environment
into the laboratory, which may release them from the selection
pressures that we wish to understand.
In parallel, progress has been made in understanding how bac-
terial populations respond to selection through in vitro experi-
mental evolution. These studies show that phenotypic dynamics
result not only in response to the environment but also, to social
interactions as bacteria cooperate and compete with one another
(2). Selection to outcompete neighbors can even lead to loss of
traits that increase survival in the environment but are costly to
produce (3–5). Such loss has been shown for a range of traits, such
as extracellular enzymes, signaling molecules, and iron chelators (2).
These exoproducts act as “public goods”: products that are bene-
ficial to the group but vulnerable to exploitation by cheats that reap
the benefit without paying the cost (6). Understanding selection on
public goods is clinically relevant, because many are virulence
factors (7, 8), and social interactions have also been shown ex-
perimentally to affect infection dynamics in vivo (9, 10).
We investigate the importance of social interactions in in-
fectious populations of Pseudomonas aeruginosa, which is both a
model organism of social evolution research and the primary
cause of chronic lung infection in patients with the genetic dis-
order cystic fibrosis (CF). CF patients usually acquire their first
P. aeruginosa infection in childhood, and these infections can
persist for years, despite antibiotic treatment (11). P. aeruginosa
produces an iron-scavenging molecule, pyoverdine, that acts as a
cooperative public good in vitro (12). Iron is essential for growth
but bound to transferrin, heme, and hemoglobin in the human
host (13). P. aeruginosa circumvents this by releasing pyoverdine,
which binds to iron and is taken up by a specific receptor. De-
tection of pyoverdine and expression of pyoverdine genes in sputum
samples confirm that the pathway is active, and likely beneficial, in
the CF lung environment (14, 15). However, cells that are deficient
in production (i.e., potential cheaters) have also repeatedly been
isolated from patients (16, 17). The pyoverdine metabolism is,
therefore, an ideal system for testing whether social dynamics ob-
served in the laboratory also occur in human hosts.
Our aim is to identify selection pressures driving any changes
that we observe in pyoverdine production in the lung. Pyoverdine
production may be an adaptive response to acquire a limited
nutrient. It may be lost, therefore, in response to availability
of other iron sources (18–20). Alternatively, production may be
lost from the population even if iron is limiting as a result of
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cooperator–cheat dynamics. Crucially, patterns of evolution of
the pyoverdine system differ depending on whether adaptation
to the human lung or social interactions drive selection (Fig. 1).
If pyoverdine does not provide a growth benefit in the lung, the
entire system will be redundant, including receptor function. In
contrast, if pyoverdine production is lost because of cheating,
receptor function will remain beneficial as long as extrinsic
pyoverdine is available. Only when cheating is not possible does
the receptor also become redundant. We can, therefore, distin-
guish between the two selection pressures by determining if and
when receptor function is maintained in bacteria that have lost
the ability to produce pyoverdine.
Two Danish collections of genome-sequenced P. aeruginosa iso-
lates provide the opportunity to study selection on pyoverdine
metabolism in CF patients (Dataset S1). The first collection gives a
detailed insight into changes occurring during the first 10 y of in-
fection across 36 young CF patients with 54 different clone types
(21), representing the transition from initial colonization to chronic
infection. With frequent and extensive sampling from each patient
(451 isolates; on average, 13 per patient), we can estimate the point
of colonization of each clone type and thereby, the time period over
which a given isolate has evolved. The second collection provides
insight into the long-term dynamics of two clone types causing
chronic infections, with samples from 24 adult patients (85 isolates)
infected with the two Danish transmissible clone types DK1 and
DK2 (22–24). The two transmissible clone types established and
spread in the Danish CF patient group from 1973 and all of the
older patients (who got chronically infected up to the beginning of
the 1990s) harbor one or both of these. Afterward, segregation of
patients in the clinic has largely eliminated transmission of these
clone types. The DK1 and DK2 isolates, thus, typically come from
now older CF patients who have each been sampled a few times,
providing insight into the long-term dynamics but not on a fine scale
at the early infection stage. For some of the analyses, as specified
below, only the isolates from the young patients have been used.
Pyoverdine Producers and Nonproducers Co-Occur Within
Patients
To detect changes in pyoverdine production during infection, we
first measured pyoverdine production in 529 isolates covering
more than 240 y of infection. For the first collection of isolates
from regularly sampled patients, this analysis revealed a long-
term decline in pyoverdine production from the point of colo-
nization of the lung [Markov chain Monte Carlo generalized
linear mixed model: b = −481 relative fluorescence units (RFUs)
standardized by cell density per year since colonization, P =
0.018] (Fig. S1 and Table S1). Isolates that produced less pyo-
verdine than a threshold were classified as nonproducers. These
nonproducers exhibited severely reduced abilities to grow in
iron-limited media [Welch two-sample t test: t = −14.81, degrees
of freedom (df) = 64.46, P < 0.01]; they comprised 12% of the
collection (n = 54 isolates of 14 clone types) and were found in
41% (n = 15) of the young patients (Fig. S2). The nonproducers
were sampled throughout the length of infection, but the pro-
portion of nonproducers to producers increased with time (Fig.
S3), resulting in a significantly later mean time of sampling for
nonproducers (t = 4.14, df = 63.32, P < 0.001). Of the trans-
missible DK1 and DK2 isolates from the second collection, 64%
(n = 50 isolates of two clone types from 20 patients) did not
produce pyoverdine. Pyoverdine production varies greatly across
the duration of infection, and there is frequently co-occurrence
of producers and nonproducers within patients, providing the
possibility for nonproducers to cheat by exploiting the supply of
pyoverdine provided by other cells (Fig. S2).
Selection Targets Genes Involved in Both Pyoverdine
Production and Uptake
Sequence analysis supports the argument that pyoverdine me-
tabolism is a target of selection. The pyoverdine region is well-
characterized (25), and the distribution of mutations across the
pyoverdine genes in isolates from both collections was not ran-
dom: two genes accumulated a higher number of mutations than
expected by a random distribution. One is the σ-factor affecting
pyoverdine biosynthesis, pvdS (pyoverdine sigma factor) [8.6×
higher; P(X ≥ 14) ∼ poisson distribution (pois) (X; 1.63) < 0.001]
(Fig. 2). Expression of pvdS initiates pyoverdine production (Fig. 1),
and therefore, a KO of this is the most efficient way to stop
production, because no costly intermediate compounds will be
produced. The second target is the gene for the specific pyo-
verdine receptor, fpvA (ferric pyoverdine receptor A) [4.9×
higher; P(X ≥ 34) ∼ pois(X; 6.92) < 0.001] (Fig. 2). Mutations in
genes affecting receptor function were only observed in non-
producing isolates. These results suggest that not only pyoverdine
production but also its uptake is under selection in the lung.
To test whether the lung or social interactions are driving
selection on the pyoverdine region, we first ensure that the un-
derlying assumptions made by both hypotheses are met. The first
hypothesis is that the observed mutations in the receptor genes
compromise the ability to take up the ferripyoverdine complex,
and growth assays supported this claim. We purified pyoverdine
from producing isolates, and the effect of the addition of this to
nonproducing isolates growing in iron-limited media was de-
pendent on the presence of receptor mutations. Although growth
in both groups was stimulated, likely because of the presence
of small amounts of other iron chelators (such as pyocyanin),
isolates without mutations showed a significantly higher in-
crease than those with mutations (t = 3.13, df = 18.63, P < 0.05)
(Fig. 3A).
The second assumption is that maintenance of the receptor is
costly and that retention, therefore, indicates selection on the
ability to uptake the ferripyoverdine complex. Our data also
support this, because the high mutation rate of the receptor gene
fpvA suggests that it is a target of selection. The cost is unlikely to
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Fig. 1. The pyoverdine system. (Upper) The pyoverdine receptor FpvA spans
the cell wall. In the absence of bound pyoverdine, the anti-σ factor FpvR
inhibits the expression of σ-factors FpvI and PvdS. Pyoverdine acquires iron
from transferrin. When ferripyoverdine binds to the receptor, FpvR releases
FpvI and PvdS. Release of FpvI initiates synthesis of the receptor FpvA, and
PvdS initiates synthesis of pyoverdine (illustrated by arrows). (Lower Left) If
pyoverdine production is lost as an adaptation to the lung, receptor function
also becomes redundant, irrespective of whether pyoverdine produced by
neighbors is available. (Lower Right) However, if pyoverdine production is
lost because of cheating, we expect to see retention of receptor function in
the presence of pyoverdine produced by others and function only lost in the
absence of pyoverdine.
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be that of biosynthesis alone, because receptor expression is
partly regulated by the binding of the ferripyoverdine complex,
limiting expression in the absence of pyoverdine (Fig. 1). How-
ever, phage-like elements, such as some pyocins, can exploit the
pyoverdine receptor and may select for modifications (26). In
support of this idea, we found by protein structure prediction
that mutations were significantly biased toward the extracellular
region of the receptor, where interaction with and recognition of
ligands occur [1.8× higher; P(X ≥ 20) ∼ pois(X; 10.88) < 0.05]
(Fig. 4). Additional support for a cost of even low receptor
expression comes from the transmissible DK2 clone type. In
1973, DK2 acquired a mutation in the σ-factor fpvI gene, can-
celing up-regulation of receptor expression in the presence of
pyoverdine (Fig. 1) and also, lowering background receptor ex-
pression (18, 27). This mutation is, however, followed by no
fewer than 17 unique nonsynonymous fpvA mutations in nine
independent lines across patients, suggesting that even limited
background expression of fpvA is costly.
Social Interactions Drive Selection on Pyoverdine
Metabolism
Given that the receptor is costly to maintain for isolates not pro-
ducing pyoverdine, we then tested if the possibility of cheating
selects for retention of receptor function. We found that the social
environment, indeed, is key, because loss of function was de-
pendent on loss of pyoverdine production by coinfecting isolates
and not the focal isolate. In the presence of pyoverdine producers,
where cheating is possible, mutations in the receptor genes [fpvA,
fpvR, and fpvI (named after fecR and fecI in E. coli)] are very rare.
However, in the absence of extrinsic pyoverdine, the number of
mutations is significantly higher than expected for fpvA [P(X ≥ 33) ∼
pois(X; 5.06) < 0.001] and the anti-σ factor fpvR [P(X ≥ 6) ∼ pois
(X; 2.1) < 0.05]. For fpvI, P(X ≥ 3) ∼ pois(X; 0.82) = 0.05 (Fig. 3B).
Longitudinal sampling of nonproducing isolates from 10 patients
further allowed us to measure latency to respond to changes in the
social environment (Materials and Methods). Cheaters maintain
receptor function for at least 4.6 y when co-occurring with pyo-
verdine-producers (n = 4 clone types; extent of sampling of
nonproducers within a patient between 0.28 and 4.6 y). In con-
trast, mutations accumulate significantly faster in the absence of
extrinsic pyoverdine—in less than 2 y after loss of pyoverdine
(n = 6 clone types; nonproducers acquire mutations in receptor
genes between 0 and 1.8 y after pyoverdine producers were last
sampled from the patient, χ2 = 5.4, df = 1, P < 0.05) (Fig. 3C).
In conclusion, we find that the pyoverdine system of P. aeru-
ginosa infecting lungs evolves in response to changes in the social
environment, as has been found in vitro (12). Iron availability is
likely to also be an important selection pressure on the pyo-
verdine system, which is evidenced by the persistence of this trait
over years of infection in some patients. Some isolates of the
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Fig. 3. Distribution of receptor mutations supports a social adaptation scenario. (A) Presence of receptor mutations predicts function. Nonproducing isolates
were grown with and without the addition of pyoverdine. Isolates without mutations (n = 16 lines of 15 clone types) showed greater induction of growth
compared with those with mutations (n = 7 lines of 5 clone types; P < 0.05). Box plots of the difference in OD600 with and without pyoverdine. The middle
band represents the median, the bottom and top boxes represent the 25th and 75th percentiles, respectively, and the lower and upper whiskers represent the
5th and 95th percentiles, respectively. (B) The number of observed mutations in genes affecting receptor synthesis is higher than expected in the absence of
pyoverdine producers (colors follow those in Fig. 1) but not in the presence of pyoverdine producers (green bars), shown as mutations observed per mutations
expected. *P < 0.05 for fpvR and fpvA. (C) Loss of receptor function is dependent on the social environment. Kaplan–Meier graph showing that the prob-
ability of acquiring receptor mutations is significantly higher when cheating on pyoverdine producers is not possible (blue line; n = 6) compared with when it
is (green line; n = 4). Ticks show when the samples were censored.
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DK1 clone type, for example, still produce pyoverdine, despite
nearly 40 y of infection history. Crucially, however, the fitness
benefits of cheating are sufficient to lead to loss of this trait from
the population repeatedly. The conditions determining whether
cooperation persists or breaks down are currently unknown.
Subsequently, P. aeruginosa will have to acquire iron through
other routes. Intriguingly, two independent studies (one on some
of the isolates described here) find that the loss of pyoverdine
production is followed by a shift toward private iron acquisition
through increased expression of heme receptors without the use
of siderophores (18, 20). This finding supports a general pattern
of breakdown of cooperative behaviors late in infection (17).
This study shows that cooperator–cheat interpretations of
clinical observations can be warranted, such as those in the recent
study by Köhler et al. (28), which suggested that P. aeruginosa
quorum sensing (QS) mutants in acute lung infections arise as
cheats and not because QS is redundant in the lung. Furthermore,
an intriguing experimental demonstration of the potential clini-
cal relevance of microbial social interactions comes from the
work by Koch et al. (29), which showed that intraspecific com-
petition can select for antibiotic-resistant Staphylococcus aureus
bacteria in the absence of antibiotic pressure. Together with
studies on cooperator–cheat dynamics in natural populations of
bacteria, such as iron acquisition of Vibrio in seawater (30) and
toxin production in Bacillus infecting moth larvae (31), this
finding calls for a reevaluation of how we interpret evolutionary
change of natural microbial populations.
Materials and Methods
Sampling. P. aeruginosa samples were collected by bronchoalveolar lavage
and endolaryngal suction and from expectorates or acquired during endo-
scopic sinus surgery at the Copenhagen Cystic Fibrosis Center, Rigshospitalet
as described previously (32). From a culture plate of the samples, one to four
isolates were selected as representative of the dominant microbiota. For the
study of early evolution of the pyoverdine system, 451 isolates of 54 dif-
ferent clone types from 36 young CF patients were included. The patient age
at first infection varied from 1.4 to 25.7 y (mean ± SD = 9.38 ± 6.15 y), and
the samples were collected over a range of 0.5–10.17 y for each patient (21).
To address the long-term adaptations, 85 isolates of the two Danish trans-
missible clone types DK1 and DK2 from 24 patients were added (seven
samples were available as genome sequences only) that were sampled be-
tween 1973 and 2012 (22–24).
Measurement of Pyoverdine Production. Pyoverdine production was measured
following the work by Kümmerli et al. (33). Isolates were cultured from
frozen stocks in 2 mL King’s B (KB) medium in 24-well plates and incubated
overnight at 37 °C. The cultures were read at optical density 600 nm (OD600),
standardized to an OD600 of 0.1 by dilution with M9 minimal media, and
inoculated into 96-well plates with iron-limited casamino acid (CAA) me-
dium (200 μL media, 2 μL culture in six replicates). After incubation for 48 h
at 37 °C, the fluorescence was measured at 400/460 nm excitation/emission
with a 475-nm cutoff in addition to OD600. Pyoverdine production per cell
was calculated as RFUs corrected for OD600. No reliable measurements were
obtained from 45 isolates, because they failed to grow in the iron-limited
media (OD600 > 0.03 after 48 h of incubation). These isolates were scored as
nonproducers and assigned a fluorescence measure of 150 RFUs standard-
ized by OD, comparable with that of other nonproducing isolates when
grown in iron-limited CAA medium. For the low-producing isolates, there
was a distinct gap between isolates producing <880 RFUs standardized by
OD (54 isolates; lower 11.5th quantile of the distribution) and the remainder
producing >2,020 RFUs standardized by OD. The former were classified
as nonproducers.
The effect of the length of infection on pyoverdine production was tested
in R (www.R-project.org) with a Markov chain Monte Carlo generalized
linear mixed model using the MCMCglmm package (34). The length of in-
fection at sampling time was estimated as the number of years since the first
recording of the sampled clone type in the patient. The pvd type and patient
identification were included as random effects. The random effects were
assigned uninformative priors, and the model was run with 3 million itera-
tions, of which the first 500,000 iterations were discarded as burn in. Sample
distributions were visualized in R with the ggplot2 package (35). The three
pvd types previously characterized for P. aeruginosa were all present in
young patients. The pvd type II (214 isolates and 25 clone types) was found
to dominate in 16 patients; the pvd type I (175 isolates and 22 clone types)
was found to dominate in 13 patients, 1 patient had two isolates of the pvd
type I and two isolates of the pvd type II, and 5 patients predominantly had
pvd type III (62 isolates and 7 clone types). In 19 patients, more than one
P. aeruginosa clone type was found, and in 12 of these, multiple pvd types
were present. The mean RFUs standardized by OD were significantly higher
for pvd type I than for pvd types II and III and significantly lower for pvd type
II compared with pvd type III (nonproducers were excluded; one-way
ANOVA, F = 69.98, df = 2, P > 0.001).
Test of Receptor Function. The 54 isolates from young patients and the 50
isolates from older patients whowere found to not produce pyoverdine were
tested for their ability to take up pyoverdine, because this uptake is a pre-
requisite for them to act as cheats. A purified sterile solution of pyoverdine
was obtained following the work by Meyer et al. (36). In short, a producing
strain was grown in 5 mL CAA overnight at 37 °C and 9 × g, transferred to
250 mL CAA, and grown overnight at 37 °C and 14 × g. The culture was
centrifuged at 9,400 × g for 15 min, and the supernatant was passed
through an XAD-4 Amberlite Column. The column was washed with ddH2O,
and the pyoverdine was eluted with methanol and distilled deionized water
(ddH20) [50%/50% (vol/vol)], dried, dissolved in ddH2O, filter-sterilized, and
standardized so that 2 μL inoculated in 200 μL CAA was equivalent to the
RFUs of a WT-producing isolate after 24 h of culture. The nonproducing
isolates were grown in KB medium overnight; OD600 standardized to 0.1 and
2 μL inoculated into a 96-well plate with iron-limited CAA media in six
replicates with and without purified pyoverdine were added to the media.
Wells with purified pyoverdine without cells served as negative controls.
OD600 was measured after 24 h of incubation at 37 °C as described above.
The growth induction was calculated as the difference in OD600 between
cells grown with and without pyoverdine after 24 h of growth. Non-
producers were tested with pyoverdine of their own pvd type. The distri-
bution of clone types in the collection of nonproducing isolates was heavily
skewed toward the transmissible DK1 and DK2 isolates. To account for this
skew, the average growth increase was calculated for each clone type for
each independent line of mutations, resulting in 16 lines of 15 different
clone types without receptor mutations and 7 different clone types with
receptor mutations, of which 3 were DK1 lines. Bacterial fitness in iron-
limited CAA is strongly correlated with the production of pyoverdine (37). To
confirm that an observed fitness benefit by the addition of supernatant was
L1
L2
L3
L4L5
L6
L7
L8L9
L10
L11
Fig. 4. Receptor mutations found in the fpvA IIA receptor gene mapped
onto the predicted transmembrane β-barrel of FpvA IIA. The β-sheets are
represented by gray boxes, and the loops are represented by black lines. The
extracellular loops are numbered L1–L11. Yellow stars indicate one non-
synonymous SNP or indel, orange stars represent two nonsynonymous SNPs
or indels, and a red star represents four events. In L8, five adjacent amino
acids were found to be altered by mutations (one of these amino acids four
times, twice in both the DK1 and DK2 clonetype).
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caused by pyoverdine, the experiment was repeated in CAA not iron-limited
by apotransferrin for nine isolates, representing all three pvd types. These
controls showed no significant effect of added pyoverdine when iron is not
bound by transferrin (paired t test: t = 0.74, df = 8, P = 0.48).
Identification of Mutations in Pyoverdine Genes.Mutations in genes known to
be important for the production of pyoverdinewere identified by sequencing
isolates [Illumina HiSeq for isolates from the young patients as described
previously (21) and Illumina’s GAIIx or HiSeq2000 for the transmissible DK1
and DK2 clone types as described previously (22–24)]. Previously unpublished
sequences are described in Dataset S2. The reads were mapped to reference
sequences with the Burrows–Wheeler alignment tool (bio-bwa.sourceforge.
net), and alignments were generated with the paired-end reads setting or
single-end reads setting. Alignments were filtered to remove unmapped
reads, sorted, and indexed, and each isolate was assigned to a read group
using Picard Tools (broadinstitute.github.io/picard/). Differences between
isolates of the same clone type were identified using Samtools (samtools.
sourceforge.net), and mutations were manually checked using IGV (www.
broadinstitute.org/igv). Dataset S5 shows the full pipeline used. Whether
SNPs were synonymous or nonsynonymous was determined manually in
ExPASy translate (web.expasy.org/translate). Reads from all isolates were
mapped to four reference regions: the pvdS/pvdG/pvdL region containing
the σ-factor controlling the main pyoverdine operon; the main pyoverdine
operon containing 17 genes, which is highly diverse with three different
variants characterized (25); the pyoverdine chromophore (pvc) region coding
the chromophore biosynthesis gene cluster; and the gene for the alternative
pyoverdine receptor fpvB (Datasets S3 and S4). For one patient with 18
isolates, the sequencing depth was only of sufficient quality to determine
the clone type and not SNPs and indels between isolates. Larger deletions
were called conservatively, and therefore, varying sequencing depth of, in
particular, some of the single-end reads may have caused some of such
events to not have been identified. Isolates of one of the transmissible
strains of the Copenhagen CF community, DK1, were observed in one pa-
tient as a result of transmission from an older patient (21). Mutations in
these and the isolates from the second collection were identified by com-
parison with the WT-like isolates of both from 1973.
Mutations were identified in 56 of the isolates from the young patients, 12
clone types from 13 patients, and 68 isolates from of the DK1 and DK2 clone
types from 19 patients (including 11 isolates of DK1 from a young patient).
We identified 171 nonsynonymous SNPs, 35 deletions, 3 insertions, 93 syn-
onymous SNPs, and 8 intergenic mutations from the complete isolate col-
lection (Datasets S3 and S4). For each gene, we calculated the expected
number of mutations given a random distribution. This expected value was
found as the total number of independent nonsynonymous SNPs and indels
(209) divided by the average size of the pyoverdine region (72.228 kb) times
the gene size (0.39–13.02 kb). Two genes (pvdJ and pvdI) differ in size be-
tween the pyoverdine types, and an average was used. The pvdD gene is only
found in types I and III, and the expected number of mutations was weighted
by the distribution of pvd- types (22% of samples with mutations were of types
I and III). The probability of finding the observed distribution of mutations was
calculated per gene as P(X ≥ mutationsobserved) ∼ pois(X; mutationsexpected) <
0.05. All mutations were classified as having occurred in the presence (27% of
all mutations) or absence of pyoverdine production (73% of all mutations;
sampling of a producing isolate from the same patient less than 1 y before the
mutation occurred). For the receptor genes (fpvI, fpvA, and fpvR), the expected
number of mutations in the presence and absence of pyoverdine was compared
with the observed as described above. The older patients harboring DK1 and
DK2 isolates had been sampled less frequently than the young patients, and
therefore, the order of mutations accumulating could not always be inferred.
When an isolate had acquired mutations affecting both production and re-
ceptor, we expected that production had been lost first, but in these cases, all
mutations were characterized as having occurred in the absence of production.
Mutations in the fpvA receptor gene were further localized to functional
regions. The crystal structure of the pvd type I receptor has been resolved
(38), but this protein has only 28% similarity at the amino acid level, with
types II and IIA receptors harboring 94% of the mutations. With the PRED-
TMBB tool (bioinformatics.biol.uoa.gr/PRED-TMBB), the strands and loops of
the β-barrel of FpvA I, FpvA II, FpvA IIA, and FpvA III were predicted, and for
FpvA I, a good congruence with the known crystal structure was found. Of
34 mutations, 31 were found in the β-barrel of the receptor (Fig. 4). The
extracellular loops of the β-barrel make up 32% of the protein, but 20
mutations (58%) were found in the coding regions for these loops. Two
mutations were in the plug part of the protein, and the remainder was in
the β-sheets (5), the cytosolic loops (3), or the N terminus of the receptor (3).
For nonproducing isolates, we tested whether mutations in receptor genes
fpvI, fpvA, and fpvR were more likely to occur in the absence than in the
presence of pyoverdine producers and at the timescale at which mutations
occur. For the majority of patients, we only had one nonproducing sample of
a given clone type (27 samples; one had an fpvA mutation), but for four
patients, we had two or more longitudinal samples of nonproducing isolates
(the same clone type with the same mutations) where pyoverdine-producing
isolates had been sampled <1 y before the nonproducers. The extent of
sampling of nonproducers from each of these patients varied between 0.28
and 4.6 y. None of these carried mutations in the receptor genes. For six
patients, we had nonproducing isolates where no other producers had been
sampled >1 y before. All of these lines acquired receptor mutations over the
sampling period. Three lines had been sampled repeatedly <2 y apart (after
1.58, 1.6, and 1.8 y), and mutations were assumed to have occurred in this
short timeframe. The third was the transmissible DK2 line first sampled as a
WT pyoverdine-producing strain in 1973 from one patient and then later the
same year, from another patient with a mutation in both σ-factor genes,
pvdS and fpvI. Both were assumed to have been mutated within 1 y. The last
two were DK1 transmissible clone types, where the first isolate sampled
from the patient was negative for both production and receptor and thus,
scored as having lost receptor function within the first year of production
loss, although the exact timing was unclear. For one of these patients, P28F1,
producing isolates were also sampled, but whole-genome phylogenetic
analysis following the work by Markussen et al. (22) suggested that the first
receptor mutation had occurred in patient P46F0 in the absence of pyo-
verdine producers and subsequently, had been transmitted to P28F1. The
analysis was run first with the latter two cases scored as receptor lost within
1 y of loss of pyoverdine production and subsequently, more conservatively
without these two lines. Using the survival package in R (39), we compared
the probability of acquiring no receptor mutations in the presence or ab-
sence of producing isolates. In both cases, we found a significant difference,
because mutations only accumulated in the absence of pyoverdine [χ2 = 5.4
(all samples)/4.2 (two samples excluded), df = 1, P < 0.05].
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